CYP26A1 Is a Novel Cancer Biomarker of Pancreatic Carcinoma: Evidence from Integration Analysis and In Vitro Experiments

BACKGROUND: CYP26A1 has been reported in multiple cancers. However, the role of CYP26A1 in pancreatic cancer (PC) has not been explored. METHOD: The public data used for this study was obtained from The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO), and Cancer Cell Line Encyclopedia (CCL...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Yi, Wang, Yunxing, Zou, Yufeng, Yu, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192288/
https://www.ncbi.nlm.nih.gov/pubmed/35707714
http://dx.doi.org/10.1155/2022/5286820

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192288/
https://www.ncbi.nlm.nih.gov/pubmed/35707714
http://dx.doi.org/10.1155/2022/5286820

Ejemplares similares